- Telehealth Visits
- Insurance plan information
Peter Sanftner, NP
General SurgeryPeter Sanftner, NP
General SurgeryGeneral Surgery Parnassus
- Telehealth Visits
- Insurance plan information
On this page
About me
Peter Sanftner is a nurse practitioner who specializes in caring for patients who are undergoing general surgery. For patients undergoing surgery, his care extends from their initial consultation through hospitalization and follow-up appointments.
Sanftner received his master's degree from the UCSF School of Nursing. He has worked at UCSF since 2007.
Education & training
Board certification
- Acute Care Nurse Practitioner, American Nurses Cred Center - Acute Care NP
Degree
- MSN, UCSF School of Nursing
My expertise
Specialties
Conditions
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%222503%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222503%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.